title: [Isolation rate of E. coli from surgical infections and their susceptibilities].
abstract: Escherichia coli isolated from surgical infections during the period from July 1983 to June 1995 were investigated in a multicenter study involving 19 hospitals in Japan, and the following results were obtained. 1. Although the isolation rate of E. coli was not high from postoperative infections, it was most frequently isolated from primary infections throughout the study period. E. coli, Klebsiella spp. and anaerobic bacteria were predominant from fresh infections. From the cases that had previous antibiotics treatment, Enterococcus spp. were the most predominant isolates followed by MRSA and Pseudomonas spp. in this order. 2. Against E. coli, cefozopran, carumonam and aztreonam had the strongest activity, followed by cefmenoxime, imipenem, latamoxef, gentamicin and ofloxacin. Recently, we have noticed that antibiotic resistant E. coli strains particularly against cefazolin are increasing year by year.
authors: Department of Surgery, Nagoya City Koseiin Hospital, Japan.
authors: N
authors: N
authors: Shinagawa
authors: J
authors: J
authors: Yura
authors: T
authors: T
authors: Manabe
authors: K
authors: K
authors: Mashita
authors: S
authors: S
authors: Ishikawa
authors: A
authors: A
authors: Mizuno
authors: K
authors: K
authors: Hirata
authors: R
authors: R
authors: Denno
authors: M
authors: M
authors: Mukaiya
authors: K
authors: K
authors: Ishibiki
authors: Y
authors: Y
authors: Ushijima
authors: N
authors: N
authors: Aikawa
authors: K
authors: K
authors: Takuma
authors: S
authors: S
authors: Iwai
authors: M
authors: M
authors: Kunimatsu
authors: H
authors: H
authors: Kinoshita
authors: K
authors: K
authors: Morimoto
authors: M
authors: M
authors: Fujimoto
authors: H
authors: H
authors: Tanimura
authors: H
authors: H
authors: Ohnishi
authors: K
authors: K
authors: Noguchi
authors: S
authors: S
authors: Mizobata
authors: Y
authors: Y
authors: Umemoto
authors: K
authors: K
authors: Orita
authors: S
authors: S
authors: Oda
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001424:Bacterial Infections / Q000382:microbiology*; D002437:Cefazolin / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects / Q000302:isolation & purification*; D006801:Humans; D007564:Japan; D008826:Microbial Sensitivity Tests; D011183:Postoperative Complications / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D002437:Cefazolin